In the last decade, FasterCures and many stakeholders across the biomedical research ecosystem have driven initiatives to ensure that patients’ perspectives and input are appropriately represented across the product-development continuum and post-approval phase. FasterCures embarked on a series of activities to gather information about current advances in patient engagement and opportunities for action to drive meaningful progress. This report summarizes our assessment of the science of patient input, including areas that have seen the greatest progress, opportunities for action to accelerate the inclusion of patients’ perspectives in research, and the next steps for stakeholder action.
Related Content
-
Citi's Christopher Hite Joins FasterCures Advisory Board
Hite’s decades of healthcare finance experience will enhance center’s approach to biomedical innovation WASHINGTON, August 13, 2019 – FasterCures, a center of the Milken Institute, today announced the appointment of Christopher Hite, Vice...Read Article -
Milken Institute Global Conference Scheduled for October 17-20, 2021
Los Angeles – April 15, 2021 – The Milken Institute Global Conference, an annual convening of global leaders in government, finance, health, academia, and philanthropy, will take place this fall from October 17-20, 2021 at The Beverly...Milken Institute Global Conference Scheduled for October 17-20, 2021
-
2023-2026 National Health Security Strategy (NHSS)
Submitted electronically Ms. Dawn O’Connell Assistant Secretary for Preparedness and Response HHS Office of the Assistant Secretary for Preparedness and Response (ASPR) 200 Independence Ave. Washington, DC 20201 Re: 2023-2026 National...Read LetterImageEsther Krofah
Executive Vice President, Milken Institute HealthEsther Krofah is the executive vice president of Milken Institute Health, leading FasterCures, Public Health, the Future of Aging, and Feeding Change. She has extensive experience managing efforts to unite diverse stakeholders to solve critical issues and achieve shared goals that improve patients’ lives. -
Patient-Reported Outcomes: Design with the End in Mind
“What outcomes matter to patients?” This question is asked at nearly every meeting in biomedical R&D and health care. As FasterCures has documented over the years, there is a big change afoot to place patients in the center of medical...Read Report -
Obesity in the Workplace: What Employers Can Do Differently
The Milken Institute Center for Public Health (the Center) focuses on chronic disease research, policy evaluation, and thought leadership by convening experts and stakeholders. As part of this work, the Center aims to change the public’s...Read Report -
America's Obesity Crisis: The Health and Economic Costs of Excess Weight
This study calculates the prevalence and economic effects of diseases related to obesity and overweight in the United States. These costs are paid by individuals and their households, employers, government, and society. The prevalence of...Read Report11 11Hugh Waters and Marlon Graf -
COVID-19 Silver Linings for Biomedical Innovation: Implementation Roadmap
While the response to the COVID-19 pandemic has exposed many of the fault lines in the biomedical innovation ecosystem that have slowed progress for decades, we have also shown ourselves capable of innovating in ways we perhaps did not...Read Report -
Request for Proposals: Misophonia
The Misophonia Research Fund is pleased to release the 2023 Request for Proposals. The General Grant Program RFP is soliciting research proposals that aim to characterize misophonia, develop objective methods to assess misophonia, or...Read Report -
Clinical Developments in Follicular Lymphoma
Follicular lymphoma (FL) is a rare, slow-growing cancer that affects certain blood cells. People experiencing this form of non-Hodgkin lymphoma face multiple relapses over the course of their disease, which can run for years and sometimes...Read ReportImageCaitlyn Barrett, PhD
Director, Science Philanthropy Accelerator for Research and Collaboration (SPARC) team, Milken Institute Strategic PhilanthropyCaitlyn Barrett, PhD, is a director on the Science Philanthropy Accelerator for Research and Collaboration (SPARC) team at Milken Institute Strategic Philanthropy. Her scientific expertise in cancer biology and neurodegeneration in addition to her experience in grant and program management, stakeholder engagement, and program analysis are brought to bear as she partners with philanthropists to maximize their impact on the biomedical ecosystem. -
2024 Policy Priorities and Solutions
We advance our policy priorities through government engagement, independent research, and convening global leaders in finance, health, government, and philanthropy to discuss challenges and opportunities facing the world.Read Report -
Defining and Demonstrating the Value of Patient Engagement in Medtech Research and Product Development
In 2022, FasterCures published a report titled The Current Landscape of the Science of Patient Input, which examined the progress of patient engagement (PE) in biomedical research and identified ways to overcome ongoing challenges. Building...Read Report -
Raleigh, NC and Gainesville, GA Top Milken Institute’s 2025 Annual Ranking of Best-Performing Cities
January 14, 2025 (Los Angeles, CA)—Raleigh, NC is the best-performing large metropolitan area, according to the 2025 Milken Institute Best-Performing Cities (BPC) report, taking the top spot in the rankings following two consecutive years...Read ArticleImagePaul Guequierre
Director, Strategic CommunicationsPaul Guequierre is the director of strategic communications. In this role, he works to increase the profile of Milken Institute in the media, raise the visibility of issues important to the organization and its stakeholders, and expand the Institute's digital presence.